Chronic HCV infection: An internist’s opinion (Part 2)

Chronic HCV infection: An internist’s opinion (Part 2)

Hepatitis C virus (HCV) infection results in not only chronic hepatitis and subsequent complications as liver cirrhosis and hepatocellular carcinoma, but also in a significant number of other diseases, the so-called extrahepatic manifestations of chronic HCV infection. In addition to lymphoprolifera...

Full description

Bibliographic Details
Main Authors:	M L Zubkin, V I Chervinko, Yu V Ovchinnikov, E V Kryukov, O N Kotenko
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2016-11-01
Series:	Терапевтический архив
Subjects:	chronic hcv infection extrahepatic manifestations direct-acting antiviral agents
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/32129/pdf

Similar Items

Chronic hepatitis C virus infection: An internist’s opinion (Part 1)
by: M L Zubkin, et al.
Published: (2016-10-01)

Frequency of Gallstones in Anti-HCV Antibody Positive Patients in a Tertiary Care Hospital of Larkana
by: Azizullah Jalbani, et al.
Published: (2019-12-01)

Update on Hepatitis C
Published: (2017)

Recurrence of Cryoglobulinemia Secondary to Hepatitis C in a Patient with HCV RNA (−) Negative in the Serum
by: Małgorzata Sikorska-Wiśniewska, et al.
Published: (2021-06-01)

Reversal of T Cell Exhaustion in Chronic HCV Infection
by: Sylwia Osuch, et al.
Published: (2020-07-01)

Vasculitic syndromes in hepatitis C virus: A review
by: Gaafar Ragab, et al.
Published: (2017-03-01)

SVR 24 Achievement Two Weeks After a Tripled Dose of Daclatasvir in an HCV Genotype 3 Patient
by: Sara Lo Menzo, et al.
Published: (2018-07-01)

CONCORDANCE OF NON-INVASIVE TESTS FOR LIVER FIBROSIS IN HCV PATIENTS PROPOSED FOR TREATMENT WITH DIRECT ACTING ANTIVIRALS
by: Andreea Cazan, et al.
Published: (2018-09-01)

Case-term Adverse Outcomes of Chronic Hepatitis C, Extrahepatic Manifestations of a Young Man Infected in Early Childhood
by: S. V. Baramzina, et al.
Published: (2015-12-01)

Use of Direct-Acting Antivirals for the Treatment of Hepatitis C Virus-Associated Oral Lichen Planus: A Case Report
by: Kenji Misaka, et al.
Published: (2016-10-01)

HCV-infected individuals have higher prevalence of comorbidity and multimorbidity: a retrospective cohort study
by: Curtis L. Cooper, et al.
Published: (2019-08-01)

Virologic Tools for HCV Drug Resistance Testing
by: Slim Fourati, et al.
Published: (2015-12-01)

Genotypic resistance testing of HCV – is there a clinical need?
by: Walker, Andreas, et al.
Published: (2016-08-01)

Consequences of extrahepatic manifestations of hepatitis C viral infection (HCV)
by: Agnieszka Pawełczyk
Published: (2016-04-01)

Treatment of the chronic hepatitis C complicated by mixed cryoglobulinemia with direct-acting antiviral agents
by: N. V. Dunaeva, et al.
Published: (2018-12-01)

A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients
by: Michael Duerr, et al.
Published: (2019-02-01)

HCV-RELATED VASCULITIS
by: Shafiq Ahmad Joya, et al.
Published: (2021-07-01)

Whole-genome characterization and resistance-associated substitutions in a new HCV genotype 1 subtype
by: von Massow G, et al.
Published: (2019-04-01)

Efficacy of treatment with Ombitasvir, Paritaprevir / r + Dasabuvir over 8 versus 12 weeks in chronic HCV hepatitis genotype 1b
by: Mircea Manuc, et al.
Published: (2021-03-01)

Cost-effectiveness analysis with direct-acting antivirals in a cohort of HCV-infected inmates in Italy
by: Roberto Ravasio, et al.
Published: (2020-12-01)

HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents
by: Andrea Angeletti, et al.
Published: (2019-02-01)

Role of a clinical pharmacist as part of a multidisciplinary care team in the treatment of HCV in patients living with HIV/HCV coinfection
by: Olea Jr A, et al.
Published: (2018-08-01)

Hepatitis C core antigen: a simple predictive marker for treatment response to the new direct-acting antiviral drugs in chronic HCV Egyptian patients
by: Asmaa M. Elbrolosy, et al.
Published: (2021-03-01)

The interaction of morphological changes in the liver with the development of extrahepatic manifestations in patients with chronic hepatitis C
by: Yu. Yu. Riabokon, et al.
Published: (2018-04-01)

Interferon-Free Regimen: Equally Effective in Treatment Naive and Experienced HCV Patients
by: Crina Fofiu, et al.
Published: (2019-01-01)

Successful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma
by: Yumiko Nagao, et al.
Published: (2017-11-01)

The efficacy and safety of direct-acting antiviral agents in patients with chronic HCV infection and UGT1A1*28 polymorphism
by: Lukashyk S.P., et al.
Published: (2020-03-01)

Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study
by: Luca Rinaldi, et al.
Published: (2019-08-01)

Cryoglobulinemia and its correlation with clinical extrahepatic manifestations in chronic hepatitis C
by: Joanna Jabłońska, et al.
Published: (2017-12-01)

A Prospective Italian Study on Baseline NS3 and NS5A Resistance to Direct-Acting Antivirals in a Real-World Setting of HIV-1/HCV Coinfected Patients and Association with Treatment Outcome
by: Sabrina Bagaglio, et al.
Published: (2020-02-01)

Challenges of transferring rural adults with chronic HCV infection for further HCV RNA confirmation and free DAAs treatment: a success story of the interdisciplinary collaboration approach
by: Wei Li, et al.
Published: (2020-10-01)

Direct-Acting Antiviral Treatment of HCV Infection Does Not Resolve the Dysfunction of Circulating CD8+ T-Cells in Advanced Liver Disease
by: Agatha Vranjkovic, et al.
Published: (2019-08-01)

Sofosbuvir in therapy of chronic HCV-infection
by: C. S. Pavlov, et al.
Published: (2016-12-01)

Evaluation of direct-acting antivirals and antiretroviral therapy for HIV-HCV coinfected patients in the United States
by: Rivera, Josef Kyle Concepcion
Published: (2021)

Real-World Effectiveness of Direct-Acting Antiviral Regimens against Hepatitis C Virus (HCV) Genotype 3 Infection: A Systematic Review and Meta-Analysis
by: Liwei Zhuang, et al.
Published: (2021-07-01)

Effectiveness of direct-acting antivirals in Hepatitis C virus infection in haemodialysis patients
by: Soraya Abad, et al.
Published: (2017-03-01)

Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland
by: Karoline Aebi-Popp, et al.
Published: (2016-01-01)

Hepatic decompensation associated with an interferon-free antiviral therapy in patients with HCV-cirrhosis
by: S N Batskikh, et al.
Published: (2018-11-01)

Efficacy and safety of direct-acting antiviral agent regimens in a real-world cohort of adult Chinese patients with chronic hepatitis C virus infection
by: Jinyuan Wei, et al.
Published: (2020-06-01)

Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district
by: Polilli E, et al.
Published: (2016-09-01)